Important options available--from start to finish--for translating proteomics results to clinical chemistry

Niels H H Heegaard, Ole Østergaard, Justyna M C Bahl, Martin Overgaard, Hans C Beck, Lars Melholt Rasmussen, Martin Røssel Larsen

    7 Citations (Scopus)

    Abstract

    In the realm of clinical chemistry, the field of clinical proteomics, that is, the application of proteomic methods for understanding mechanisms and enabling diagnosis, prediction, measurement of activity, and treatment response in disease, is first and foremost a discovery and research tool that feeds assay development downstream. Putative new assay candidates generated by proteomics discovery projects compete with well-established assays with known indications, well-described performance, and of known value in specific clinical settings. Careful attention to the many options available in the design, execution, and interpretation of clinical proteomics studies is thus necessary for translation into clinical practice. We here review and discuss important options associated with clinical proteomics endeavors stretching from the planning phases to the final use in clinical chemistry.

    Original languageEnglish
    JournalProteomics - Clinical Applications
    Volume9
    Issue number1-2
    Pages (from-to)235-52
    Number of pages18
    ISSN1862-8346
    DOIs
    Publication statusPublished - 1 Feb 2015

    Keywords

    • Biomarkers/analysis
    • Clinical Medicine
    • Humans
    • Proteome/analysis
    • Proteomics/methods

    Fingerprint

    Dive into the research topics of 'Important options available--from start to finish--for translating proteomics results to clinical chemistry'. Together they form a unique fingerprint.

    Cite this